Cancer cells are masters at avoiding detection, but a new system developed by Yale scientists can make them stand out from the crowd and help the immune system spot and eliminate tumors that other forms of immunotherapies ...
Oct 14, 2019
0
1100
The emerging field of synthetic biology—designing new biological components and systems—is revolutionizing medicine. Through the genetic programming of living cells, researchers are creating engineered systems that intelligently ...
Jul 3, 2019
0
6
During infection or tumor growth, a type of specialized white blood cells called CD8+ T cells rapidly multiply within the spleen and lymph nodes and acquire the ability to kill diseased cells. Some of these killer T cells ...
Dec 11, 2017
0
861
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy will be successful, can now determine which lung-cancer patients ...
Nov 23, 2019
1
226
For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.
May 13, 2020
0
63
Cancer patients on immunotherapy fare worse if they have recently taken antibiotics, with their response and overall survival rate "crashing."
Sep 13, 2019
0
463
Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.
Nov 8, 2017
0
534
Researchers at UPMC Hillman Cancer Center and the National Cancer Institute (NCI) demonstrate that changing the gut microbiome can transform patients with advanced melanoma who never responded to immunotherapy—which has ...
Feb 4, 2021
0
667
More than 81,000 new cases of bladder cancer will be diagnosed in the U.S. in 2022, and more than 17,000 people will die of the disease, according to the American Cancer Society.
Jun 1, 2022
0
2
Johns Hopkins Medicine researchers have added to evidence that a gene responsible for turning off a cell's natural "suicide" signals may also be the culprit in making breast cancer and melanoma cells resistant to therapies ...
Sep 1, 2020
0
120
